Callan Jmb Inc. (CJMB) — Insider Trading

AI-Powered SEC Filing Analysis

Latest Insider Trading Filed: 2026-03-26

Key Insights

The filing shows that David J. Croyle, a director and 10% owner of CALLAN JMB INC. (CJMB), acquired 10,195 shares of the company's common stock on March 20, 2026 at a price of $1.75 per share.
This transaction increases Croyle's beneficial ownership to 800,000 shares, which are held indirectly through a Rollover IRA.
Insider buying, especially by directors and large shareholders, can be a positive signal about the company's prospects and future stock performance.

Want the newest filings?

This analysis covers the filing from 2026-03-26. In the app, any new 10-K, 10-Q or 8-K is analyzed the moment you open it.

Download on theApp Store Get it onGoogle Play

Get it on Google Play Open in app →

Earlier Insider Trading filings

Filed: 2026-03-10

David J. Croyle, Chief Medical Officer and 10% owner of CALLAN JMB INC., has purchased 14,805 shares of the company's common stock at $1.762 per share, increasing his indirect beneficial ownership to 789,805 shares.
The transaction indicates that an insider with significant ownership believes the company's stock is undervalued and sees potential for future growth.
Insider buying is often viewed as a positive signal for a company's prospects, as executives have strong incentives to generate shareholder value.

Filed: 2026-01-06

The reporting person, Gerald Dial, acquired 2,000 shares of the issuer's common stock on December 30, 2025, indicating an increase in his direct ownership of the company's securities.
Dial was also granted a stock option to purchase 25,000 shares of the issuer's common stock, which vests on the first-year anniversary of the company's initial public offering.
The stock purchases and option grant suggest Dial's confidence in the company's future prospects and alignment with shareholder interests.

Other reports for Callan Jmb Inc.

Quarterly Report Current Report Annual Report

Important Information

AI-generated analysis is for informational purposes only. Always read original SEC filings and consult with qualified professionals before making investment decisions.